TENOSYNOVIAL GIANT CELL TUMOR
Clinical trials for TENOSYNOVIAL GIANT CELL TUMOR explained in plain language.
Never miss a new study
Get alerted when new TENOSYNOVIAL GIANT CELL TUMOR trials appear
Sign up with your email to follow new studies for TENOSYNOVIAL GIANT CELL TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
First human trial tests promising new pill for Tough-to-Treat cancers
Disease control Recruiting nowThis is an early-stage study to test the safety and determine the best dose of a new oral medication called ABSK021 in people with advanced solid tumors that have stopped responding to standard treatments. The trial will enroll about 276 participants, including those with a rare …
Matched conditions: TENOSYNOVIAL GIANT CELL TUMOR
Phase: PHASE1 • Sponsor: Abbisko Therapeutics Co, Ltd • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC
-
Glowing dye could help surgeons spot hidden tumors
Diagnosis Recruiting nowThis study is testing a new imaging method to help surgeons see a rare joint tumor more clearly during surgery. Patients receive a safe dye before their operation that makes the tumor glow under a special camera. The goal is to see if this glowing light helps surgeons find and re…
Matched conditions: TENOSYNOVIAL GIANT CELL TUMOR
Phase: PHASE4 • Sponsor: Shanghai Jiao Tong University Affiliated Sixth People's Hospital • Aim: Diagnosis
Last updated Mar 30, 2026 14:28 UTC
-
10-Year watch: tracking liver dangers of rare tumor drug
Knowledge-focused Recruiting nowThis study follows patients for up to 10 years to better understand the long-term risk of serious liver problems in people who took TURALIO for a rare joint tumor. Researchers will track 30 adults who developed specific liver test abnormalities while on the medication. The goal i…
Matched conditions: TENOSYNOVIAL GIANT CELL TUMOR
Sponsor: Daiichi Sankyo • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:10 UTC
-
Tracking a new Drug's Real-Life impact on rare tumor patients
Knowledge-focused Recruiting nowThis study aims to learn how patients with a rare, non-cancerous joint tumor (TGCT) use the drug vimseltinib in everyday medical practice. It will observe about 100 patients who are already prescribed this medication to see how long they stay on treatment and how it affects their…
Matched conditions: TENOSYNOVIAL GIANT CELL TUMOR
Sponsor: Deciphera Pharmaceuticals, LLC • Aim: Knowledge-focused
Last updated Mar 24, 2026 12:02 UTC